Illustration of the relative zones of inhibition of screened compounds versus MU1140 and OG253.
Johan A. Kers
Anthony W. DeFusco
Jae H. Park
Jin Xu
Mark E. Pulse
William J. Weiss
Martin Handfield
10.1371/journal.pone.0197467.g003
https://plos.figshare.com/articles/figure/Illustration_of_the_relative_zones_of_inhibition_of_screened_compounds_versus_MU1140_and_OG253_/6494795
<p>Controls are boxed in the upper-left corner and include blanks (Column 1, negative control), MU1140 (Column 2, positive control) and OG253 (Column 3, comparator).</p>
2018-06-12 18:01:08
substitution variants
performer
OG 716
lantibiotic Mutacin 1140
fit-for-purpose lantibiotic
vivo testing
novel antibiotics
novel lantibiotic
infections Lantibiotics
MU 1140-derived variants
novel mechanism
CDI
hamster model
CDAD
3 weeks post infection
biologically-relevant systems